Gesundheit
US FDA approves GE HealthCare’s diagnostic drug for the treatment of heart disease
The US Food and Drug Administration has approved a GE HealthCare diagnostic drug for use in detecting coronary heart disease, the company said on Friday.
Sanofi-Regeneron’s Dupixent drug has received FDA approval for ‘smoker’s lungs’
The U.S. Food and Drug Administration approved Sanofi and Regeneron companies said Friday that the blocker drug Dupixent is intended for patients with chronic lung
CSL gets $121 million contract to increase US avian flu vaccine stockpile to 40 million doses
Australia’s CSL said it has been awarded a $121.4 million contract by the US Department of Health and Human Services to increase the US government’s
Pfizer recalls sickle cell anaemia drug due to risk of complications and death
US drugmaker Pfizer said on Wednesday it was recalling Oxbryta, a treatment for sickle-cell anaemia, from all markets where it is approved, citing risks of
Evotec and Novo Nordisk join forces in technology development partnership
German pharmaceutical and research company Evotec has entered into a technology development partnership with Novo Nordisk Evotec said on Thursday it intends to support the
US will donate 1 million doses of mpox vaccine to stop outbreak in Africa
U.S. President Joe Biden announced the donation of 1 million doses of mpox vaccine and at least $500 million to African countries to support their
The US FDA has approved IntraBio for the treatment of a rare genetic disease
The U.S. Food and Drug Administration has approved a drug from IntraBio to treat a rare and deadly genetic disease, the health regulator said Tuesday,
Amgen’s muscle disorder drug has achieved a major late-stage study goal
Amgen said Tuesday that its drug helped improve daily activities, including chewing and swallowing, in patients suffering from a rare disease that causes muscle weakness,
Eli Lilly’s Alzheimer’s drug approved in Japan
Japan’s Ministry of Health has approved Eli Lilly’s Alzheimer’s drug donanemab, giving patients another treatment option after Eisai and Biogen’s Leqembi received the go-ahead in
Novo Nordisk faces US scrutiny over drug prices
US Senator Bernie Sanders is set to grill Novo Nordisk CEO Lars Jorgensen over the prices of Wegovy, the weight loss and diabetes drug, which